Citation: Hui FENG, Kang-hong HU. Structural Characteristics and Molecular Mechanism of Hepatitis B Virus Reverse Transcriptase .VIROLOGICA SINICA, 2009, 24(6) : 509-517.  http://dx.doi.org/10.1007/s12250-009-3076-6

Structural Characteristics and Molecular Mechanism of Hepatitis B Virus Reverse Transcriptase

cstr: 32224.14.s12250-009-3076-6
  • Corresponding author: Kang-hong HU, hukgh@wh.iov.cn
  • Received Date: 19 May 2009
    Accepted Date: 24 June 2009
    Available online: 01 December 2009

    Fund Project: National Nature Science Foundations of China 30870131Program of Chinese Academy of Sciences 0802021SA1

  • Hepatitis B virus (HBV), a typical member of the Hepadnaviridae family, is responsible for infections that cause B-type hepatitis which leads to severe public health problems around the world. The small enveloped DNA-containing virus replicates via reverse transcription, and this unique process is accomplished by the virally encoded reverse transcriptase (RT). This multi-functional protein plays a vital role in the viral life cycle. Here, we provide a summary of current knowledge regarding the structural characteristics and molecular mechanisms of HBV RT. Improved understanding of these processes is of both theoretical and practical significance for fundamental studies of HBV and drug discovery.

  • 加载中
    1. Bartenschlager R, Schaller H. 1992. Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO J, 11 (9): 3413-3420.

    2. Beck J, Nassal M. 1997. Sequence-and structure-specific determinants in the interaction between thε RNA encapsidation signal and reverse transcriptase of avian hepatitis B viruses. J Virol, 71 (7): 4971-4980.

    3. Beck J, Nassal M. 1998. Formation of a functional hepatitis B virus replication initiation complex involves a major structural alteration in thε RNA template. Mol Cell Biol, 18 (11): 6265-6272.
        doi: 10.1128/MCB.18.11.6265

    4. Beck J, Nassal M. 2003. Efficient Hsp90-independent in vitro activation by Hsc70 and Hsp40 of duck Hepatitis B virus reverse transcriptase, an assumed Hsp90 client protein. J Biol Chem, 278 (38): 36128-36138.
        doi: 10.1074/jbc.M301069200

    5. Beck J, Nassal M. 2007. Hepatitis B virus replication. World J Gastroenterol, 13 (1): 48-64.
        doi: 10.3748/wjg.v13.i1.48

    6. Beck J, Vogel M, Nassal M. 2002. dNTP versus NTP discrimination by phenylalanine 451 in duck hepatitis B virus P protein indicates a common structure of the dNTP-binding pocket with other reverse transcriptases. Nucl Acids Res, 30 (7): 1679-1687.
        doi: 10.1093/nar/30.7.1679

    7. Chen Y, Marion P L. 1996. Amino acids essential for RNase H activity of hepadnaviruses are also required for efficient elongation of minus-strand viral DNA. J Virol, 70 (9): 6151-6156.

    8. Chen Y, Robinson W S, Marion P L. 1994. Selected mutations of the duck hepatitis B virus P gene RNase H domain affect both RNA packaging and priming of minus-strand DNA synthesis. J Virol, 68 (8): 5232-5238.

    9. Feng H, Hu K. 2008. Aptamers against viral hepatitis: from rational design to practical application. Virol Sin, 23 (5): 315-320.
        doi: 10.1007/s12250-008-2979-y

    10. Gao W, Hu J. 2007. Formation of Hepatitis B Virus Covalently Closed Circular DNA: Removal of Genome-Linked Protein. J Virol, 81 (12): 6164-6174.
        doi: 10.1128/JVI.02721-06

    11. Girard F C, Ottink O M, Ampt K A. et al. 2007. Thermodynamics and NMR studies on Duck, Heron and Human HBV encapsidation signals. Nucl Acids Res, 35 (8): 2800-2811.
        doi: 10.1093/nar/gkm131

    12. Habig J W, Loeb D D. 2006. Sequence identity of the direct repeats, DR1 and DR2, contributes to the discrimination between primer translocation and in situ priming during replication of the duck hepatitis B virus. J Mol Biol, 364 (1): 32-43.
        doi: 10.1016/j.jmb.2006.08.095

    13. Haines K M, Loeb D D. 2007. The sequence of thε RNA primer and the DNA template influence the initiation of plus-strand DNA synthesis in hepatitis B virus. J Mol Biol, 370 (3): 471-480.
        doi: 10.1016/j.jmb.2007.04.057

    14. Hu J, Boyer M. 2006. Hepatitis B virus reverse trans-criptase and ε RNA sequences required for specific interaction in vitro. J Virol, 80 (5): 2141-2150.
        doi: 10.1128/JVI.80.5.2141-2150.2006

    15. Hu J, Flores D, Toft D, et al. 2004. Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function. J Virol, 78 (23): 13122-13131.
        doi: 10.1128/JVI.78.23.13122-13131.2004

    16. Hu J, Lin L. 2009. RNA-protein interactions in hepadnavirus reverse transcription. Front Biosci, 14: 1606-1618.

    17. Hu J, Nguyen D. 2004. Therapy for chronic hepatitis B: the earlier, the better? Trends Microbiol, 12 (10): 431-433.
        doi: 10.1016/j.tim.2004.08.007

    18. Hu J, Seeger C. 1996. Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc Natl Acad Sci USA, 93 (3): 1060-1064.
        doi: 10.1073/pnas.93.3.1060

    19. Hu J, Toft D, Anselmo D, et al. 2002. In vitro reconstitution of functional Hepadnavirus reverse trans-criptase with cellular chaperone proteins. J Virol, 76 (1): 269-279.
        doi: 10.1128/JVI.76.1.269-279.2002

    20. Hu J, Toft D, Seeger C. 1997. Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids. EMBO J, 16 (1): 59-68.
        doi: 10.1093/emboj/16.1.59

    21. Hu K, Beck J, Nassal M. 2004. SELEX-derived aptamers of the duck hepatitis B virus RNA encapsidation signal distinguish critical and non-critical residues for productive initiation of rever transcription. Nucl Acids Res, 32 (14): 4377-4389.
        doi: 10.1093/nar/gkh772

    22. Huang H, Chopra R, Verdine G L, et al. 1998. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science, 282 (5394): 1669-1675.
        doi: 10.1126/science.282.5394.1669

    23. Joyce C M. 1997. Choosing the right sugar: how poly-merases select a nucleotide substrate. Proc Natl Acad Sci USA, 94 (5): 1619-1622.
        doi: 10.1073/pnas.94.5.1619

    24. Kim H Y, Kim H Y, Jung J, et al. 2008. Incorporation of deoxyribonucleotides and ribonucleotides by a dNTP-binding cleft mutated reverse transcriptase in hepatitis B virus core particles. Virology, 370 (1): 205-212.
        doi: 10.1016/j.virol.2007.08.018

    25. Lanford R E, Notvall L, Lee H, et al. 1997. Transcomplementation of nucleotide priming and reverse transcription between independently expressed TP and RT domains of the hepatitis B virus reverse transcriptase. J Virol, 71: 2996-3004.

    26. Lin L, Hu J. 2008. Inhibition of hepadnavirus reverse transcriptase-epsilon RNA interaction by porphyrin compounds. J Virol, 82 (5): 2305-2312.
        doi: 10.1128/JVI.02147-07

    27. Lin X, Ma Z M, Yao X, et al. 2005. Substitution of proline 306 in the reverse transcriptase domain of hepatitis B virus regulates replication. J Gen Virol, 86 (1): 85-90.
        doi: 10.1099/vir.0.80581-0

    28. Lin X, Yuan Z H, Wu L, et al. 2001. A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency. J Virol, 75 (23): 11827-11833.
        doi: 10.1128/JVI.75.23.11827-11833.2001

    29. Liu N, Ji L, Maguire M L, et al. 2004. cis-Acting sequences that contribute to the synthesis of relaxed-circular DNA of human hepatitis B virus. J Virol, 78 (2): 642-649.
        doi: 10.1128/JVI.78.2.642-649.2004

    30. Nassal M. 2008. Hepatitis B viruses: Reverse transcription a different way. Virus Research, 134 (1-2): 235-249.
        doi: 10.1016/j.virusres.2007.12.024

    31. Nassal M, Rieger A. 1996. A bulged region of the hepatitis B virus RNA encapsidation signal contains the replication origin for discontinuous firststrand DNA synthesis. J Virol, 70 (5): 2764-2773.

    32. Nassal M, Schaller H. 1994. Hepatitis B virus replication. Trends Microbiol, 1 (6): 221-228.

    33. Ono S K, Kato N, Shiratori Y, et al. 2001. The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance. J Clin Invest, 107(4): 449-455.
        doi: 10.1172/JCI11100

    34. Potenza N, Salvatore V, Raimondo D, et al. 2007. Optimized expression from a synthetic gene of an untagged RNase H domain of human hepatitis B virus polymerase which is enzymatically active. Protein Expr Purif, 55 (1): 93-99.
        doi: 10.1016/j.pep.2007.04.005

    35. Radziwill G, Tucker W, Schaller H. 1990. Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J Virol, 64 (2): 613-620.

    36. Schaaf S G, Beck J, Nassal M. 1999. A small 2'-OH-and base-dependent recognition element downstream of the initiation site in thε RNA encapsidation signal is essential for hepatitis B virus replication initiation. J Biol Chem, 274 (53): 37787-37794.
        doi: 10.1074/jbc.274.53.37787

    37. Seeger C, Mason W S. 2000. Hepatitis B virus biology. Microbiol Mol Biol Rev, 64 (1): 51-68.
        doi: 10.1128/MMBR.64.1.51-68.2000

    38. Stahl M, Beck J, Nassal M. 2007. Chaperones Activate Hepadnavirus Reverse Transcriptase by Transiently Exposing a C-Proximal Region in the Terminal Protein Domain That Contributes to ε RNA Binding. J Virol, 81 (24): 13354-13364.
        doi: 10.1128/JVI.01196-07

    39. Stahl M, Retzlaff M, Nassal M, et al. 2007. Chaperone activation of the hepadnaviral reverse transcriptase for templatε RNA binding is established by the Hsp70 and stimulated by the Hsp90 system. Nucleic Acids Research, 35(18): 6124-6136.
        doi: 10.1093/nar/gkm628

    40. Summers J, Mason W S. 1982. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell, 29 (2): 403-415.
        doi: 10.1016/0092-8674(82)90157-X

    41. Van Hemert F J, Zaaijer H L, Berkhout B, et al. 2008. Mosaic amino acid conservation in 3D-structures of surface protein and polymerase of hepatitis B virus. Virology, 370 (2): 362-372.
        doi: 10.1016/j.virol.2007.08.036

    42. Wang G H, Seeger C. 1992. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell, 71 (4): 663-670.
        doi: 10.1016/0092-8674(92)90599-8

    43. Wang G H, Seeger C. 1993. Novel mechanism for reverse transcription in hepatitis B viruses. J Virol, 67 (11): 6507-6512.

    44. Wang X, Qian X, Guo H C, et al. 2003. Heat shock protein 90-independent activation of truncated Hepadnavirus reverse transcriptase. J Virol, 77 (8): 4471-4480.
        doi: 10.1128/JVI.77.8.4471-4480.2003

    45. Ying C, Li Y, Leung C H, et al. 2007. Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue. Proc Natl Acad Sci USA, 104 (20): 8526-8531.
        doi: 10.1073/pnas.0609883104

    46. Zoulim F, Seeger C. 1994. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J Virol, 68 (1): 6-13.

  • 加载中

Figures(2)

Article Metrics

Article views(9933) PDF downloads(37) Cited by()

Related
Proportional views

    Structural Characteristics and Molecular Mechanism of Hepatitis B Virus Reverse Transcriptase

      Corresponding author: Kang-hong HU, hukgh@wh.iov.cn
    • State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China
    Fund Project:  National Nature Science Foundations of China 30870131Program of Chinese Academy of Sciences 0802021SA1

    Abstract: Hepatitis B virus (HBV), a typical member of the Hepadnaviridae family, is responsible for infections that cause B-type hepatitis which leads to severe public health problems around the world. The small enveloped DNA-containing virus replicates via reverse transcription, and this unique process is accomplished by the virally encoded reverse transcriptase (RT). This multi-functional protein plays a vital role in the viral life cycle. Here, we provide a summary of current knowledge regarding the structural characteristics and molecular mechanisms of HBV RT. Improved understanding of these processes is of both theoretical and practical significance for fundamental studies of HBV and drug discovery.